We use cookies to better understand how you use our site and to improve your experience by personalizing content. Please review our updated Privacy Policy and Terms of Use. If you accept the use of cookies, please click the "I accept" button.I acceptI declineX
Skip navigational links

Life Sciences Newsletter, December 2009


Volume 3, Issue 3
Editor: Karen Gibbs, Esquire

  • Authorized Generics: FTC Releases Interim Report
    Aimee DeFilippo, Esquire

  • Teva Wins District Court Reviewability Battle But Loses 180 Day Exclusivity Forfeiture War Against FDA in Cozaar/Hyzaar Litigation
    Arnold Friede, Esquire

  • Medical Diagnostic Claims Are Patentable
    Kathleen Van De Loo, Esquire
    Jacob Zambrzycki
    Jonathan Anastasia

  • Personalized Medicine and the Changing Intellectual Property Landscape: Updating the Freedom to Operate Analysis
    Paul Radensky, Esquire
    Dov Greenbaum, Esquire

  • United States v. Textron: What Life Science Counsel Needs to Know About Evolving Case Law on the Work Product Privilege
    Brian Stimson, Esquire
© 2018 American Health Lawyers Association. All rights reserved. 1620 Eye Street NW, 6th Floor, Washington, DC 20006-4010 P. 202-833-1100 F. 202-833-1105